Cadre Holdings plans $3.0M stock sale on NYSE

Cadre Holdings, Inc. (CDRE) reports a planned sale of common stock under Form 144.

Rhea-AI Filing Summary

Cadre Holdings, Inc. (CDRE) reports a planned sale of common stock under Form 144. The notice covers common shares with an aggregate market value of 3,029,651.88, with 42,820,734 common shares outstanding as context. The proposed transaction date is August 17, 2026 on the NYSE. The shares relate to the exercise of stock options42,770 and 45,972 shares.

Key Figures

Aggregate market value of securities: 3,029,651.88 Shares outstanding: 42,820,734 shares Option-related block 1: 42,770 shares +2 more

5 metrics

Aggregate market value of securities 3,029,651.88 Related to common stock covered by the Form 144 notice

Shares outstanding 42,820,734 shares Common shares outstanding as referenced in the Form 144

Option-related block 1 42,770 shares Common shares tied to exercise of stock options for cash

Option-related block 2 45,972 shares Additional common shares tied to exercise of stock options for cash

Proposed transaction date 08/17/2026 Intended date of sale for the common stock on the NYSE

Key Terms

Form 144, aggregate market value, exercise of stock options, securities to be sold

4 terms

Form 144 regulatory

"reports a planned sale of common stock under Form 144"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

aggregate market value financial

"shares with an aggregate market value of 3,029,651.88"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

exercise of stock options financial

"relate to the exercise of stock options for cash"

securities to be sold financial

"The notice covers common shares in the securities to be sold"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Cadre Holdings (CDRE) disclose in this Form 144 filing?

Cadre Holdings (CDRE) discloses a planned sale of common stock under Form 144, tied to the exercise of stock options for cash, with a proposed transaction date of August 17, 2026 on the NYSE.

How many Cadre Holdings (CDRE) shares are tied to the option exercises in this Form 144?

The Form 144 lists two blocks of Cadre Holdings (CDRE) common stock related to option exercises: 42,770 shares and 45,972 shares, both associated with the exercise of stock options for cash on August 17, 2026.

What aggregate market value is reported for the Cadre Holdings (CDRE) Form 144 shares?

The filing reports an aggregate market value of 3,029,651.88 for the Cadre Holdings (CDRE) common shares covered. This figure relates to the securities to be sold as disclosed in the Form 144 securities information section.

How many Cadre Holdings (CDRE) shares are outstanding according to this Form 144?

According to the Form 144 disclosure, Cadre Holdings (CDRE) has 42,820,734 common shares outstanding. This serves as a context figure alongside the proposed sale and does not represent the amount being sold.

When are the Cadre Holdings (CDRE) Form 144 sales expected to occur?

The Form 144 specifies a proposed transaction date of August 17, 2026 for the Cadre Holdings (CDRE) common stock. The securities are tied to the exercise of stock options for cash and are listed for trading on the NYSE.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/17/2026 - 04:44 PM Accepted by SEC EDGAR 08/17/2026 - 04:44 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001876053
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Cadre Holdings, Inc.
SEC File Number	001-40698
Address of Issuer	13386 International Pkwy Jacksonville FLORIDA 32218
Phone	9047415400
Name of Person for Whose Account the Securities are To Be Sold	Brad Williams
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	88742	3029651.88	42820734	08/17/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/17/2026	Exercise of Stock Options	Issuer			42770	08/17/2026	Cash
Common	08/17/2026	Exercise of Stock Options	Issuer			45972	08/17/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/17/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Mijo Suric, for UBS Financial Services Inc, as attorney-in-fact for Brad Williams
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)